CAS 86827-77-2
:(4R,6R)-Tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-2H-pyran-2-one
Description:
The chemical substance known as (4R,6R)-Tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-2H-pyran-2-one, with the CAS number 86827-77-2, is a complex organic compound characterized by its multi-ring structure and specific stereochemistry. It features a tetrahydropyran moiety, which contributes to its cyclic nature, and a naphthalene derivative that enhances its hydrophobic properties. The presence of hydroxyl groups indicates potential for hydrogen bonding, influencing its solubility and reactivity. This compound may exhibit biological activity, possibly serving as a precursor or intermediate in the synthesis of pharmaceuticals or natural products. Its stereochemical configuration suggests that it may interact selectively with biological targets, making it of interest in medicinal chemistry. The intricate arrangement of its functional groups and stereocenters is crucial for its chemical behavior and potential applications in various fields, including drug development and organic synthesis.
Formula:C19H30O3
InChI:InChI=1S/C19H30O3/c1-12-3-7-18-14(9-12)5-4-13(2)17(18)8-6-16-10-15(20)11-19(21)22-16/h4-5,12-18,20H,3,6-11H2,1-2H3/t12-,13+,14+,15-,16-,17+,18+/m1/s1
InChI key:InChIKey=AGNDLYBQPUJADV-VCWNUMGPSA-N
SMILES:C(C[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]2[C@@]3([C@@](C=C[C@@H]2C)(C[C@H](C)CC3)[H])[H]
Synonyms:- 2H-Pyran-2-one, tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-, (4R,6R)-
- 4a,5-Dihydromonacolin L
- (4R,6R)-Tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-2H-pyran-2-one
- Dihydromonacolin L
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Dihydromonacolin L
CAS:<p>Dihydromonacolin L is a kinase inhibitor that has shown promise in the treatment of cancer. It is derived from Chinese medicinal herbs and has been found to induce apoptosis, or programmed cell death, in cancer cells. Dihydromonacolin L has been shown to be effective against a variety of tumors, including leukemia, by inhibiting the cell cycle and inducing apoptosis. This compound is an attractive target for anticancer drug development due to its potent inhibitory activity against protein kinases. In recent studies, it has been found that Dihydromonacolin L can enhance the anticancer effects of nintedanib, another cancer drug. Overall, Dihydromonacolin L shows great potential as a new class of anticancer agents with promising therapeutic applications.</p>Formula:C19H30O3Purity:Min. 95%Molecular weight:306.4 g/mol
